Vinge advised Egetis Therapeutics on the deal. Egetis Therapeutics AB (publ), listed on Nasdaq Stockholm, completed a directed share issuances whereby Egetis Therapeutics receives gross proceeds...
Egetis Therapeutics’ Shares Offering
Hansa Biopharma’s Shares Offering
Vinge advised Hansa Biopharma AB on the deal. Hansa Biopharma AB (publ) finalized a directed share issue through which the company raises proceeds of SEK 372 million...
Triton’s Sale of Shares in Ambea
Vinge advised Triton on the deal. Triton completed the sale of shares in Ambea AB. In total, 7.7 million shares were placed at a price of SEK...
Fyndiq’s Business Combination with CDON
Cederquist advised CDON on the deal. CDON and the majority shareholders of Fyndiq, two of the leading retail marketplaces in Sweden, have agreed to combine their...
Millicom International Cellular S.A.’s $750 Million Rights Offering
Simpson Thacher and Loyens & Loeff Luxembourg represented J.P. Morgan, Nordea, Morgan Stanley and DNB Markets who acted as underwriters on the deal, while Advokatfirman Cederquist...
BillerudKorsnäs’s SEK 3.5 Billion Rights Offering
Skadden, Arps, Slate, Meagher & Flom (UK) LLP and Cederquist advised BillerudKorsnäs. Linklaters advised the Joint Global Coordinators and Joint Bookrunners. BillerudKorsnäs AB, (Nasdaq Stockholm: BILL),...
Aeternum’s Acquisition of 19.6% of The Shares in SkiStar AB
Wikborg Rein and Cederquist assisted Aeternum on the deal. Aeternum Capital AS acquired 19.55 percent of the shares and 13.78 percent of the votes in SkiStar...
Helsing’s €102.5 Million Series A Financing Round
YPOG and Blomstein advised Helsing on the deal. Cederquist and Raue advised Prima Materia. The European defence AI company Helsing announced the latest funding round with...